Document is current
Any future updates will be listed below
-
Authors
Power, Caroline
Trepanowski, Nicole https://orcid.org/0000-0001-5885-1009
Salem, Iman
Simmons, Brian https://orcid.org/0000-0003-0862-0055
- License Information
-
More Information
Article History
Received: 9 April 2025
Revised: 4 November 2025
Accepted: 5 November 2025
First Online: 28 November 2025
Declarations
:
: Dr. Simmons is an investigator for Acelyrin, AbbVie, Biofrontera, Insmed, Lilly, SmartPractice, TARGET-DERM, and Takeda, all unrelated to this research. Drs. Trepanowski and Salem are sub-investigators for Acelyrin, AbbVie, Biofrontera, Lilly, SmartPractice, TARGET-DERM, and Takeda, all unrelated to this research. Ms. Power has no conflicts of interest.
: The methodology for this study was approved by the Dartmouth Health IRB (Protocol STUDY02002597).
: This study received institutional review board approval from the Dartmouth Health IRB.
: Not Applicable.
